Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  wild-type reovirus
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: REO 022, NCI-2012-00474, NCT01274624
Wild-type Reovirus in Combination with Carfilzomib and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9603, NCI-2014-00643, 2014C0091, NCI-9603, OSU-14031, 14031, NCT02101944
Wild-Type Reovirus in Combination with Sargramostim in Treating Younger Patients with High-Grade Recurrent or Refractory Brain Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 10 to 21
Trial IDs: MC1472, NCI-2015-00665, NCT02444546
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: REO 024, NCI-2015-02218, NCT02620423
Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Multiple Myeloma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16M-15-2, NCI-2015-01069, REO 019, NCT02514382
Start Over